Featured Letters, Testimony, & Comments
BIO Comments to FDA on Alternative Tools:…
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
Letter to House and Senate Judiciary Committee…
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
BIO letter to FDA on Scientific Challenges and…
BIO submits comments in response to the agency’s request for information (FDA-2023-N-3742)
Explore BIO
BIO DOUBLE HELIX SPONSORS







BIO HELIX SPONSORS




1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2023 All Rights Reserved